文献速递心境障碍焦虑、强迫与应激相关障碍

1990至2021年中国及各省抑郁和焦虑障碍负担:2021年全球疾病负担研究结果

Burden of depressive and anxiety disorders in China and its provinces, 1990-2021: findings from the Global Burden of Disease Study 2021.
PubMed 文献 · Br J Psychiatry · 2026-01-01

基于2021年全球疾病负担研究数据,分析1990至2021年中国国家和省级层面抑郁和焦虑障碍的患病率和伤残调整生命年负担。抑郁障碍年龄标化患病率下降6.4%,焦虑障碍患病率保持稳定,COVID-19对两者均有显著不良影响。

要点

  • 抑郁障碍年龄标化患病率下降6.4%(2.9, 10.4),从每10万人3071.8降至2875.7,焦虑障碍患病率保持稳定。

核心结论

  • 过去三十年中国的抑郁和焦虑障碍负担持续上升,COVID-19期间增幅更大。
  • 疾病负担在性别、年龄组和省份间存在显著差异,是政府制定干预策略的重要因素。
  • 政府和卫生主管部门应在未来工作中考虑突发公共卫生事件对抑郁和焦虑障碍负担的潜在影响。

研究设计与样本

  • 数据来源于2021年全球疾病负担、伤害和危险因素研究(GBD 2021)。
  • 研究呈现1990至2021年中国国家和省级层面抑郁和焦虑障碍的患病率和伤残调整生命年(DALYs)负担,并按性别(GBD 2021中称为「sex」)和年龄分析。

主要发现

  • 抑郁障碍年龄标化患病率下降6.4%(95%不确定性区间:2.9, 10.4),从每10万人3071.8降至2875.7,焦虑障碍患病率保持稳定。
  • COVID-19对抑郁和焦虑障碍均有显著不良影响。
  • 疾病负担在性别、年龄组、省份和时间趋势上存在相当大的变异性,DALYs呈现相似模式。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Depressive and anxiety disorders constitute a major component of the disease burden of mental disorders in China. AIMS: To comprehensively evaluate the disease burden of depressive and anxiety disorders in China. METHOD: The raw data is sourced from the Global Burden of Disease, Injuries, and Risk Factors Study (GBD) 2021. This study presented the disease burden by prevalence and disability-adjusted life years (DALYs) of depressive and anxiety disorders at both the national and provincial levels in China from 1990 to 2021, and by gender (referred to as 'sex' in the GBD 2021) and age. RESULTS: From 1990 to 2021, the number of depressive disorder cases (from 34.4 to 53.1 million) and anxiety disorders (from 40.5 to 53.1 million) increased by 54% (95% uncertainty intervals: 43.9, 65.3) and 31.2% (19.9, 43.8), respectively. The age-standardised prevalence rate of depressive disorders decreased by 6.4% (2.9, 10.4), from 3071.8 to 2875.7 per 100 000 persons, while the prevalence of anxiety disorders remained stable. COVID-19 had a significant adverse impact on both conditions. There was considerable variability in the disease burden across genders, age groups, provinces and temporal trends. DALYs showed similar patterns. CONCLUSION: The burden of depressive and anxiety disorders in China has been rising over the past three decades, with a larger increase during COVID-19. There is notable variability in disease burden across genders, age groups and provinces, which are important factors for the government and policymakers when developing intervention strategies. Additionally, the government and health authorities should consider the potential impact of public health emergencies on the burden of depressive and anxiety disorders in future efforts.

来源:Br J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Tian W, Yan G, Xiong S, et al. Burden of depressive and anxiety disorders in China and its provinces, 1990-2021: findings from the Global Burden of Disease Study 2021. Br J Psychiatry. 2026. PMID: 39838265. doi:10.1192/bjp.2024.267

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。